PBM Transparency Included In Democrats’ Drug Pricing Deal

By Gabrielle Wanneh / November 9, 2021 at 4:37 PM

Democrats’ drug pricing deal bars pharmacy benefit managers from entering into contracts with drug makers that limit the disclosure of information to health plan sponsors, among other reporting requirements.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.